Navigation Links
Gene markers located for hereditary prostate cancer
Date:1/16/2008

Researchers at the Johns Hopkins Brady Urological Institute, Wake Forest University and the Karolinska Institute in Sweden have identified an array of gene markers for hereditary prostate cancer that, along with family history for the disease, appear to raise risk to more than nine times that of men without such markers. The panel, gleaned from a study of more than 4,000 Swedes, found that these markers are common and could account for nearly half of the prostate cancer cases in this study. Results are published online in the Jan. 16 edition of the New England Journal of Medicine.

The international research team plans to sample DNA from U.S. populations of men to determine if these genetic changes prevail outside of Sweden. And they caution that the panel of markers cannot tell how aggressive a potential cancer may be.

This information is not yet available as a genetic test for risk of prostate cancer, but efforts are under way to rapidly develop one, says William B. Isaacs, Ph.D., of the Johns Hopkins Brady Urological Institute, who participated in the study.

While these findings need to be validated and refined, its a step in the right direction to revealing the genetic-based reasons for this cancer that we have been looking for over the past 15 years, he added.

In the study, the scientists drew blood from 2,893 prostate cancer patients and 1,781 men without the disease. White blood cells are a good source of DNA that an individual is born with as opposed to DNA in cancer cells that gets altered by the environment or other means, according to the scientists.

Using DNA from blood cells, they sifted through variations in chemicals called nucleotides that pair up to form the rungs of a DNA ladder which carries genetic instructions. These so-called single nucleotide polymorphisms or SNPs, occur when one chemical base pair is swapped for another, altering the information in the DNA alphabet or sequence.

Investigators found 16 SNPs in five different regions of human chromosomes 8 and 17 that were more common to men with prostate cancer than those without the disease. The individual changes were ones previously linked to prostate cancer and other diseases, a good indication, the scientists say, that they were on the right track.

To create their panel, the scientists chose the best SNPs from each of the five regions and tested their cumulative effect on prostate cancer risk. As the number of associated SNPs increased, so did risk. Men with four or more of these SNPs were nearly 4.5 times more likely to have prostate cancer.

This work strongly suggests that because of the combination of polymorphisms we inherit, one man may be more on the path to developing prostate cancer than another, says Isaacs, who is the William Thomas Gerrard, Mario Anthony Duhon and Jennifer and John Chalsty Professor of Urology at the Brady Urological Institute and professor of oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Add to that a family history of prostate cancer and the risk doubles. Men with all five SNPs plus a family history of prostate cancer were nearly 9.5 times more likely to have the disease. Further analysis revealed that 46 percent of prostate cancer cases in this population were due to these risk factors. But the scientists estimate that almost 90 percent of the Swedish population carries one or more of the five SNPs, elevating their risk for prostate cancer relative to men who carry none of these factors.

Swedish populations are relatively homogenous, tending to marry other Swedes and well suited for such genetic studies because genetic variation is somewhat more limited than in larger, heterogeneous groups. Socialized medicine in Sweden also enables access to robust registries of patient data.

In addition, Swedes suffer from higher-grade prostate and other cancers, and deaths among their Caucasian populations are 10 to 20 percent higher than among American Caucasians, according to Henrik Gronberg, M.D., Ph.D., professor of epidemiology at the Karolinska Institute and a co-investigator on the study.

Isaacs and his team note that the SNPs may not in themselves lead to increased cancer risk, but could be markers linked to other changes that do so.

Wake Forest and Johns Hopkins Schools of Medicine have filed patent applications for the technology and results described in this study.


'/>"/>

Contact: Vanessa Wasta
wastava@jhmi.edu
410-955-1287
Johns Hopkins Medical Institutions
Source:Eurekalert

Related medicine news :

1. UCLA researchers identify markers that may predict diabetes in still-healthy people
2. Penn School of Medicine receives $2.3 million to study biomarkers of cigarette smoke exposure
3. Study makes progress in zoning in on biomarkers for better colon cancer treatment
4. Study shows blood markers can help choose best dose for antiangiogenic drugs
5. Biomarkers predict risk for invasive breast cancer years before the tumor develops
6. 2 proteins may be survival markers in some breast cancers
7. JDRF and Lilly partner to fund research to identify beta cell biomarkers
8. Biomarkers for Alzheimers disease can be trusted in clinical trials
9. New developments in biomarkers for epithelial ovarian cancer
10. Biological markers of prostate cancer shed light on cancer burden faced by African-American men
11. Blood Markers Might Predict Clotting Risk With HRT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ... agreement to be the preferred physical therapy provider for Derby City CrossFit, effective ... Derby City CrossFit as quickly and effectively as possible, ProRehab’s sports physical therapists ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent ... test score performance for the 2015-16 school year across Wisconsin’s public schools, charter ... it highlights important patterns in student test score performance, the report’s limited analyses ...
(Date:4/25/2017)... ... April 25, 2017 , ... As ... contracted partners to help with process innovation in drug formulation and manufacturing. ... along with state-of-the-art analytical equipment in support of their development and manufacturing goals. ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest ... chronic problems, I focus on preventative care with all my patients to alleviate possible future ... always feel free to contact my office and my trained staff will assist you in ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® , a ... UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event ... the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... BOSTON , April 20, 2017   ZappRx, Inc ... the specialty drug prescribing process, today announced it closed $25 ... Fund, a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included ... A round in 2014, and GV (formerly Google ...
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
(Date:4/19/2017)... April 19, 2017 Global Surgical Drainage Device ... tubes used to remove excess liquid and air. The ... urine, bile or lymph. Surgical drains are used in ... as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. ... to prevent accumulation of fluid e.g. blood or pus. ...
Breaking Medicine Technology: